130 related articles for article (PubMed ID: 19213955)
21. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
[TBL] [Abstract][Full Text] [Related]
23. Colchicine aggravates coxsackievirus B3 infection in mice.
Smilde BJ; Woudstra L; Fong Hing G; Wouters D; Zeerleder S; Murk JL; van Ham M; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA; Emmens RW
Int J Cardiol; 2016 Aug; 216():58-65. PubMed ID: 27140338
[TBL] [Abstract][Full Text] [Related]
24. Low-intensity pulsed ultrasound attenuates cardiac inflammation of CVB3-induced viral myocarditis via regulation of caveolin-1 and MAPK pathways.
Zheng C; Wu SM; Lian H; Lin YZ; Zhuang R; Thapa S; Chen QZ; Chen YF; Lin JF
J Cell Mol Med; 2019 Mar; 23(3):1963-1975. PubMed ID: 30592150
[TBL] [Abstract][Full Text] [Related]
25. The comparison of α-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms.
Zhang Y; Cao W; Xie YH; Yang Q; Li XQ; Liu XX; Wang SW
Int Immunopharmacol; 2012 Sep; 14(1):107-13. PubMed ID: 22709476
[TBL] [Abstract][Full Text] [Related]
26. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
[TBL] [Abstract][Full Text] [Related]
27. Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model.
Lim BK; Yun SH; Ju ES; Kim BK; Lee YJ; Yoo DK; Kim YC; Jeon ES
Virus Res; 2015 Mar; 199():1-8. PubMed ID: 25485472
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
Hiraoka Y; Kishimoto C; Takada H; Nakamura M; Kurokawa M; Ochiai H; Shiraki K
J Am Coll Cardiol; 1996 Nov; 28(6):1610-5. PubMed ID: 8917278
[TBL] [Abstract][Full Text] [Related]
29. Heme oxygenase-1 mediates oxidative stress and apoptosis in coxsackievirus B3-induced myocarditis.
Ursu ON; Sauter M; Ettischer N; Kandolf R; Klingel K
Cell Physiol Biochem; 2014; 33(1):52-66. PubMed ID: 24401606
[TBL] [Abstract][Full Text] [Related]
30. Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis.
Wang D; Chen Y; Jiang J; Zhou A; Pan L; Chen Q; Qian Y; Chu M; Chen C
Gene; 2014 Sep; 547(2):195-201. PubMed ID: 24905653
[TBL] [Abstract][Full Text] [Related]
31. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
Wang Y; Gao B; Xiong S
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
[TBL] [Abstract][Full Text] [Related]
32. Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells.
Funke C; Farr M; Werner B; Dittmann S; Überla K; Piper C; Niehaus K; Horstkotte D
J Gen Virol; 2010 Aug; 91(Pt 8):1959-1970. PubMed ID: 20392896
[TBL] [Abstract][Full Text] [Related]
33. Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis.
Cheung CT; Deisher TA; Luo H; Yanagawa B; Bonigut S; Samra A; Zhao H; Walker EK; McManus BM
Lab Invest; 2007 Jul; 87(7):651-61. PubMed ID: 17468777
[TBL] [Abstract][Full Text] [Related]
34. Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis.
Liu T; Yang F; Liu J; Zhang M; Sun J; Xiao Y; Xiao Z; Niu H; Ma R; Wang Y; Liu X; Dong Y
Exp Anim; 2019 Nov; 68(4):549-558. PubMed ID: 31243190
[TBL] [Abstract][Full Text] [Related]
35. Dynamic changes in myocardial matrix metalloproteinase activity in mice with viral myocarditis.
Meng XH; Wang Y; Zhuang JX; Han XZ; Chen Y; Jin YP; Wang YL; Yu YH; Spires JP; Song GJ
Chin Med J (Engl); 2004 Aug; 117(8):1195-9. PubMed ID: 15361294
[TBL] [Abstract][Full Text] [Related]
36. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
37. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
38. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
39. Activation of AMP-activated protein kinase reduces collagen production via p38 MAPK in cardiac fibroblasts induced by coxsackievirus B3.
Jiang S; Jiang D; Zhao P; He X; Tian S; Wu X; Tao Y
Mol Med Rep; 2016 Jul; 14(1):989-94. PubMed ID: 27221787
[TBL] [Abstract][Full Text] [Related]
40. An ERK-p38 subnetwork coordinates host cell apoptosis and necrosis during coxsackievirus B3 infection.
Jensen KJ; Garmaroudi FS; Zhang J; Lin J; Boroomand S; Zhang M; Luo Z; Yang D; Luo H; McManus BM; Janes KA
Cell Host Microbe; 2013 Jan; 13(1):67-76. PubMed ID: 23332156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
